Start your registration
While data becomes increasingly vital across functions and industries, it’s worth noting that around 80% of data is unstructured, and that percentage is only expected to grow, according to Gartner and other analysts.
In addition to the explosive growth of unstructured data, which prompts the necessity of natural language processing (NLP), we are also currently witnessing the emergence of new technologies such as large language models (LLMs). The buzz around LLMs is well-founded, as their potential to impact the entire drug development process is becoming increasingly indisputable as the technology continues to advance.
Check out our on-demand webinar, in which we delve specifically into the applications and benefits of LLMs and NLP techniques within the context of clinical trials. Our experts shed light on how these new technologies can revolutionize the way clinical trials are designed, making the process more efficient, accurate, and patient-centric.
Discover how you can accelerate clinical trial design to drive new treatments to market faster.